Compare YEXT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YEXT | PACB |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.0M | 462.8M |
| IPO Year | 2017 | 2010 |
| Metric | YEXT | PACB |
|---|---|---|
| Price | $3.83 | $1.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $7.50 | $1.67 |
| AVG Volume (30 Days) | 1.3M | ★ 5.4M |
| Earning Date | 06-02-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 131.82 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $170,201,000.00 | $93,468,000.00 |
| Revenue This Year | $3.95 | $11.32 |
| Revenue Next Year | $2.46 | $12.14 |
| P/E Ratio | $198.25 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $3.27 | $1.09 |
| 52 Week High | $9.20 | $2.73 |
| Indicator | YEXT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 46.00 | 50.86 |
| Support Level | $3.66 | $1.18 |
| Resistance Level | $4.14 | $1.78 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 40.15 | 22.34 |
Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.